This is a preview of subscription content, log in via an institution to check access.
References
Busch, R., Hill, C. M., Hayball, J. D., Lamb, J. R., and Rothbard, J. B. Effect of natural polymorphism at residue 86 of the HLA-DR beta chain on peptide binding.J Immunol 147: 1292–1298, 1991
Chicz, R. M., Urban, R. G., Gorga, J. C., Vignali, D. A., Lane, W. S., and Strominger, J. L. Specificity and promiscuity among naturally processed peptides bound to HLA-DR alleles.J Exp Med 178: 27–47, 1993
Davenport, M. P., Quinn, C. L., Chicz, R. M., Green, B. N., Willis, A. C., Lane, W. S., Bell, J. I., and Hill, A. V. Naturally processed peptides from two disease-resistance-associated HLA-DR13 alleles show related sequence motifs and the effect of the dimorphism at position 86 of the HLA-DRβ chain.Proc Natl Acad Sci USA 92: 6567–6571, 1995
De Bueger, M., Verreck, F., Blokland, E., Drijfhout, J. W., Amons, R., Koning, F., and Goulmy, E. Isolation of an HLA-A2.1 extracted human minor histocompatibility peptide.Eur J Immunol 23: 614–618, 1993
De Koster, H. S., van Rood, J. J., and Termijtelen, A. HLA-DR peptide-induced alloreactive T cell lines reveal an HLA-DR sequence that can be both “dominant” and “cryptic”: evidence for allele-specific processing.Eur J Immunol 22: 1531–1539, 1992
Demotz, S., Barbey, C., Corradin, G., Amoroso, A., and Lanzavecchia, A. The set of naturally processed peptides displayed by DR molecules is tuned by polymorphism of residue 86.Eur J Immunol 23: 425–432, 1993
Falk, K., Rötzschke, O., Stevanović, S., Jung, G., and Rammensee, H. G. Pool sequencing of natural HLA-DR, DQ, and DP ligands reveals detailed peptide motifs, constraints of processing, and general rules.Immunogenetics 39: 230–242, 1994
Geluk, A., van Meijgaarden, K. E., Janson, A. A., Drijfhout, J. W., Meloen, R. H., de Vries, R. R., and Ottenhoff, T. H. Functional analysis of DR17(DR3)-restricted mycobacterial T cell epitopes reveals DR17-binding motif and enables the design of allelespecific competitor peptides.J Immunol 149: 2864–2871, 1992
Hammer, J., Takacs, B., and Sinigaglia, F. Identification of a motif for HLA-DR1 binding peptides using M13 display libraries.J Exp Med 176: 1007–1013, 1992
Hammer, J., Valsasnini, P., Tolba, K., Bolin, D., Higelin, J., Takacs, B., and Sinigaglia, F. Promiscuous and allele-specific anchors in HLA-DR-binding peptides.Cell 74: 197–203, 1993
Johnson, A. H., Fang-Tang, T., Cowell, V., and Katovich-Hurley, C. The impact of naturally occurring DR3 microvariants, DRw17 and DRw18, on T-cell allorecognition.Hum Immunol 32: 46–55, 1991
Koning, F., Schreuder, M., Giphart, M., and Bruning, H. A mouse monoclonal antibody detecting a DR-related MT2-like specificity: serology and biochemistry.Hum Immunol 9: 221, 1984
Krieger, J. I., Karr, R. W., Grey, H. M., Yu, W., O'Sullivan, D., Batovsky, L., Zheng, Z., Colon, S. M., Gaeta, F. C. A., Sidney, J., Albertson, M., del Guerico, M., Chesnut, R. W., and Sette, A. Single amino acid changes in DR and antigen define residues critical for peptide-MHC binding and T cell recogntion.J Immunol 146: 2331–2340, 1991
Kropshofer, H., Max, H., Muller, C. A, Hesse, F., Stevanović, S., Jung, G., and Kalbacher, H. Self-peptide released from class II HLA-DR1 exhibits a hydrophobic two-residue contact motif.J Exp Med 175: 1799–1803, 1992
Kropshofer, H., Max, H., Halder, T., Kalbus, M., Muller, C. A., and Kalbacher, H. Self-peptides from four HLA-DR alleles share hydrophobic anchor residues near the NH2-terminal including proline as a stop signal for trimming.J Immunol 151: 4732–4742, 1993
Lang, B., LoGalbo, P. R., Sanchez, B., and Winchester, R. HLA-Dw14 and HLA-DR2 haplotypes share a functional determinant recognized by a human alloreactive T-cell clone.Hum Immunol 23: 59–70, 1988
Malcherek, G., Falk, K., Rötzschke, O., Rammensee, H. G., Stevanović, S., Gnau, V., Jung, G., and Melms, A. Natural peptide ligand motifs of two HLA molecules associated with myasthenia gravis.Int Immunol 5: 1229–1237, 1993
Marshall, K. W., Liu, A. F., Canales, J., Perahia, B., Jorgensen, B., Gantzos, R. D., Aguilar, B., Devaux, B., and Rothbard, J. B. Role of the polymorphic residues in HLA-DR molecules in allele-specific binding of peptide ligands.J Immunol 152: 4946–4957, 1994
Newcomb, J. R. and Cresswell, P. Characterization of endogenous peptides bound to purified HLA-DR molecules and their absence from invariant chain-associated alpha beta dimers.J Immunol 150: 499–507, 1993
Ong, B., Willcox, N., Wordsworth, P., Beeson, D., Vincent, A., Altmann, D., Lanchbury, J. S. S., Harcourt, G. C., Bell, J. I., and Newsom-Davis, J. Critical role for the Val/Gly86 HLA-DRβ86 dimorphism in autoantigen presentation to human T cells.Proc Natl Acad Sci USA 88: 7343–7347, 1991
Rammensee, H. G., Friede, T., and Stevanović, S. MHC ligands and peptide motifs: first listing.Immunogenetics 41: 178–228, 1995
Rebai, N., Malissen, B., Pierres, M., Accolla, R. S., Corte, G., and Mawas, C. Distinct HLA-DR epitopes and distinct families of HLA-DR molecules defined by 15 monoclonal antibodies (mAb) either anti-DR or allo-anti-lak crossreacting with human DR molecule.Eur J Immunol Eur J Immunol 13: 106–111, 1983
Stern, L. J., Brown, J. H., Jardetzky, T. S., Gorga, J. C., Urban, R. G., Strominger, J. L., and Wiley, D. C. Crystal structure of the human class II MHC protein HLA-DRI complexed with an influenza virus peptide.Nature 368: 215–221, 1994
Verreck, F. A., Termijtelen, A., and Koning, F. HLA-DR beta chain residue 86 controls DR alpha beta dimer stability.Eur J Immunol 23: 1346–1350, 1993
Verreck, F. A. W., Elferink, D., Vermeulen, C. J., Amons, R., Breedveld, F., de Vries, R. R. P., and Koning, F. DR4Dw4/DR53 molecules contain a peptide from the autoantigen calreticulin.Tissue Antigens 45: 270–275, 1995
Verreck, F. A. W., Vermeulen, C., Van de Poel, A., Jorritsma, P., Amons, R., Coligan, J. E., Drijfhout, J. W., and Koning, F. The generation of SDS stable HLA DR dimers is independent of efficient peptide binding.Int Immunol 8, in press
Vogt, A. B., Kropshofer, H., Kalbacher, H., Kalbus, M., Rammensee, H. G., Coligan, J. E., and Martin, R. Ligand motifs of HLA-DRB5*0101 and DRB1*1501 molecules delineated from self-peptides.J Immunol 153: 1665–1673, 1994
Zeliszewski, D., Tiercy, J.-M., Dorval, I., Kaplan, C., March, B., and Sterkers, G. DR-restricted T-cell locus DRB3 (DRw52c) or locus DRB1.Hum Immunol 28: 345–353, 1990
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Verreck, F.A.W., van de Poel, A., Drijfhout, J.W. et al. Natural peptides isolated from Gly86/Val86-containing variants of HLA-DR1,-DR 11, -DR13, and -DR52. Immunogenetics 43, 392–397 (1996). https://doi.org/10.1007/BF02199809
Received:
Revised:
Issue Date:
DOI: https://doi.org/10.1007/BF02199809